Antibody-containing solution pharmaceuticals
    5.
    发明申请
    Antibody-containing solution pharmaceuticals 审中-公开
    含抗体溶液药物

    公开(公告)号:US20050118163A1

    公开(公告)日:2005-06-02

    申请号:US10504025

    申请日:2003-02-14

    摘要: An antibody-containing solution formulation comprising an organic acid and a surfactant as stabilizers; a method for suppressing the formation of visible insoluble matter and/or insoluble particles due to the presence of metal ions in an antibody-containing solution formulation, which comprises adding an organic acid to the solution; a method for suppressing the formation of visible insoluble matter and/or insoluble particles during shaking and freezing-thawing of an antibody-containing solution, which comprises adding a surfactant to the solution; and a method for stabilizing an antibody-containing solution, which comprises adding an organic acid and a surfactant.

    摘要翻译: 含有有机酸和作为稳定剂的表面活性剂的含抗体的溶液制剂; 一种抑制由于在含抗体的溶液制剂中存在金属离子而导致的可见不溶物质和/或不溶性颗粒的形成的方法,其包括向溶液中加入有机酸; 包括向溶液中加入表面活性剂的方法,用于抑制在含抗体溶液的振荡和冻融过程中形成可见不溶物质和/或不溶性颗粒的方法; 以及用于稳定含抗体的溶液的方法,其包括加入有机酸和表面活性剂。

    Antibody-containing solution formulations
    6.
    发明授权
    Antibody-containing solution formulations 有权
    含抗体溶液制剂

    公开(公告)号:US08921527B2

    公开(公告)日:2014-12-30

    申请号:US12184551

    申请日:2008-08-01

    摘要: An antibody-containing solution formulation comprising an organic acid and a surfactant as stabilizers; a method for suppressing the formation of visible insoluble matter and/or insoluble particles due to the presence of metal ions in an antibody-containing solution formulation, which comprises adding an organic acid to the solution; a method for suppressing the formation of visible insoluble matter and/or insoluble particles during shaking and freezing-thawing of an antibody-containing solution, which comprises adding a surfactant to the solution; and a method for stabilizing an antibody-containing solution, which comprises adding an organic acid and a surfactant.

    摘要翻译: 含有有机酸和作为稳定剂的表面活性剂的含抗体的溶液制剂; 一种抑制由于在含抗体的溶液制剂中存在金属离子而导致的可见不溶物质和/或不溶性颗粒的形成的方法,其包括向溶液中加入有机酸; 包括向溶液中加入表面活性剂的方法,用于抑制在含抗体溶液的振荡和冻融过程中形成可见不溶物质和/或不溶性颗粒的方法; 以及用于稳定含抗体的溶液的方法,其包括加入有机酸和表面活性剂。

    Erythropoietin solution preparation
    7.
    发明授权
    Erythropoietin solution preparation 有权
    红细胞生成素溶液制剂

    公开(公告)号:US08546329B2

    公开(公告)日:2013-10-01

    申请号:US12293493

    申请日:2007-03-22

    IPC分类号: C07K14/505

    摘要: The present invention relates to an erythropoietin-containing solution preparation containing a poloxamer and having a pH of 6.5 to 7.5. The present invention also relates to a method for quantifying a protein in a trace amount, the method including the following steps: binding a protein sample to a high-intensity fluorescent dye; separating a desired analyte from the obtained sample by an appropriate separation means; and quantifying the desired analyte and converting the amount of the analyte into the amount of the protein.

    摘要翻译: 本发明涉及含有泊洛沙姆并具有6.5至7.5的pH的含促红细胞生成素的溶液制剂。 本发明还涉及一种定量微量蛋白质的方法,该方法包括以下步骤:将蛋白质样品与高强度荧光染料结合; 通过适当的分离装置从所获得的样品中分离所需的分析物; 并定量所需的分析物并将分析物的量转化为蛋白质的量。

    ERYTHROPOIETIN SOLUTION PREPARATION
    8.
    发明申请
    ERYTHROPOIETIN SOLUTION PREPARATION 有权
    ERYTHROPOIETIN溶液制备

    公开(公告)号:US20100234276A1

    公开(公告)日:2010-09-16

    申请号:US12293493

    申请日:2007-03-22

    IPC分类号: A61K38/16 A61P29/00 G01N33/68

    摘要: The present invention relates to an erythropoietin-containing solution preparation containing a poloxamer and having a pH of 6.5 to 7.5. The present invention also relates to a method for quantifying a protein in a trace amount, the method including the following steps: binding a protein sample to a high-intensity fluorescent dye; separating a desired analyte from the obtained sample by an appropriate separation means; and quantifying the desired analyte and converting the amount of the analyte into the amount of the protein.

    摘要翻译: 本发明涉及含有泊洛沙姆并具有6.5至7.5的pH的含促红细胞生成素的溶液制剂。 本发明还涉及一种定量微量蛋白质的方法,该方法包括以下步骤:将蛋白质样品与高强度荧光染料结合; 通过适当的分离装置从所获得的样品中分离所需的分析物; 并定量所需的分析物并将分析物的量转化为蛋白质的量。